These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4390371)

  • 1. Discouraging drug abuse.
    Winek CL
    N Engl J Med; 1969 Sep; 281(13):740. PubMed ID: 4390371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Althaea, ipecac, senega and thyme as cough medicines].
    Kantee H
    Sairaanhoitaja; 1973 Mar; 49(5):32. PubMed ID: 4144514
    [No Abstract]   [Full Text] [Related]  

  • 3. New abuse of ipecac.
    Ente G; Penzer PH
    Pediatrics; 1986 Jan; 77(1):134-5. PubMed ID: 2866486
    [No Abstract]   [Full Text] [Related]  

  • 4. Ipecac abuse in a sample of eating disordered outpatients.
    Greenfeld D; Mickley D; Quinlan DM; Roloff P
    Int J Eat Disord; 1993 May; 13(4):411-4. PubMed ID: 8098249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drub abuse policy in Pakistan.
    Khan I; Wadud KA
    Bull Narc; 1977; 29(4):21-40. PubMed ID: 346119
    [No Abstract]   [Full Text] [Related]  

  • 6. [New experiences with drug misuse in England].
    Retterstol N
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2123. PubMed ID: 4773991
    [No Abstract]   [Full Text] [Related]  

  • 7. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?
    Silber TJ
    J Adolesc Health; 2005 Sep; 37(3):256-60. PubMed ID: 16109351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipecac--a substance of abuse.
    Cooper C; Kilham H; Ryan M
    Med J Aust; 1998 Jan; 168(2):94-5. PubMed ID: 9469196
    [No Abstract]   [Full Text] [Related]  

  • 9. Basic elements for a national comprehensive plan for drug abuse control in Peru.
    Flores Agreda R
    Bull Narc; 1987; 39(2):37-49. PubMed ID: 3449154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug abuse involving stramonium alkaloids.
    Morano RA
    Med Leg Bull; 1972 Jan; 21(1):1-6. PubMed ID: 5010730
    [No Abstract]   [Full Text] [Related]  

  • 11. The epidemiology of ipecac abuse.
    Pope HG; Hudson JI; Nixon RA; Herridge PL
    N Engl J Med; 1986 Jan; 314(4):245-6. PubMed ID: 2867469
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders.
    Palmer EP; Guay AT
    N Engl J Med; 1985 Dec; 313(23):1457-9. PubMed ID: 2865679
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems of drug abuse and preventive measures in Poland.
    Tobolska-Rydz H
    Bull Narc; 1986; 38(1-2):99-104. PubMed ID: 3779183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipecac may not halt drug abuse.
    Gowdy JM
    N Engl J Med; 1970 Oct; 283(17):936. PubMed ID: 4394044
    [No Abstract]   [Full Text] [Related]  

  • 15. Rhinitis medicamentosa.
    Blue JA
    Ann Allergy; 1968 Aug; 26(8):425-9. PubMed ID: 4175448
    [No Abstract]   [Full Text] [Related]  

  • 16. Abuse of thorn apple.
    Henson RW; Miller LP; Herron JT
    Med J Aust; 1978 Mar; 1(5):280. PubMed ID: 661683
    [No Abstract]   [Full Text] [Related]  

  • 17. United Nations/Burma Programme for Drug Abuse Control. The first phase: 1976 to 1981.
    Zealey P
    Bull Narc; 1981; 33(3):1-21. PubMed ID: 6461372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syrup of ipecac contamination.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jun; 37(23):374. PubMed ID: 2897621
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovations in adolescent substance abuse intervention.
    Wagner EF; Brown SA; Monti PM; Myers MG; Waldron HB
    Alcohol Clin Exp Res; 1999 Feb; 23(2):236-49. PubMed ID: 10069552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent substance abuse: psychosocial factors.
    Tuttle J
    J Sch Nurs; 1993 Oct; 9(3):18, 20, 22-5. PubMed ID: 8241685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.